Form 4 for XYL Xylem Inc.
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-05 · accession 0001209191-21-063232 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-05 | 2021-11-05 | XYL | Pine Matthew Francis | SVP | M - OptEx | $63.55 | +2,000 | 39.2K | +5% | +$127.1K |
| D | 2021-11-05 | 2021-11-05 | XYL | Pine Matthew Francis | SVP | S - Sale+OE | $130.49 | -2,000 | 37.2K | -5% | -$261.0K |
| D | 2021-11-05 | 2021-11-05 | XYL | Pine Matthew Francis | SVP | M - OptEx | $0.00 | -2,000 | 42.4K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-05 | M | A | 2,000 | $63.55 | 39,217 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-05 | S | D | 2,000 | $130.49 | 37,217 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-11-05 | M | D | 2,000 | $0.00 | 42,423 | D | $63.55 · — to 2030-05-07 | 2,000 Common | (F3) The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023. |